Most a short while ago, it has been discovered that conolidine and the above mentioned derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in very similar areas as classical opioid receptors, it binds to a big range of endogenous opioids. Contrary to most opioid receptors, this receptor https://deborahx197uvv8.wikitron.com/user